GlassScriptPhysician profile
Priti Patel
NPI 1760430391
$4,851.56
in general payments reported to CMS, 2019-2025
38 companies · $813 in 2025
The $813 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $629 · 2021: $804 · 2022: $705 · 2023: $571 · 2024: $781 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,143 · Entertainment: $22.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,143.30 |
| Entertainment | $22.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $519.09 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Arbor Pharmaceuticals, INC. | $511.82 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $341.65 | 2024-2025 | |
| Ascendis Pharma Endocrinology INC | $260.09 | 2022-2025 | Skytrofa |
| Insulet Corporation | $247.32 | 2019-2025 | Omnipod |
| Novo Nordisk INC | $229.74 | 2019-2023 | Wegovy |
| Lilly USA, LLC | $218.07 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $209.91 | 2019-2024 | Sohonos |
| Beta Bionics, INC. | $193.15 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Tolmar, INC. | $192.29 | 2023-2024 | |
| Azurity Pharmaceuticals, INC. | $182.24 | 2023-2025 | Triptodur, Triptodur |
| Abbvie INC. | $181.24 | 2019-2025 | |
| Abbott Laboratories | $178.22 | 2020-2025 | Freestyle Libre 3 |
| Ultragenyx Pharmaceutical INC. | $155.47 | 2022-2023 | |
| Medtronic, INC. | $130.30 | 2021-2025 | Minimed 780g |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $128.09 | 2020-2022 | |
| Tandem Diabetes Care, INC. | $113.93 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ferring Pharmaceuticals INC. | $107.64 | 2019 | |
| Neurocrine Biosciences, INC. | $92.80 | 2024-2025 | |
| Dexcom, INC. | $86.55 | 2021-2023 | Dexcom G6 Transmitter |
| Becton, Dickinson and Company | $55.96 | 2020-2021 | |
| Sequel Med Tech, LLC | $49.70 | 2025 | Twiist |
| Kyowa Kirin, INC. | $49.23 | 2024 | Crysvita |
| Amphastar Pharmaceuticals, INC. | $44.73 | 2024-2025 | |
| Eton Pharmaceuticals, INC. | $43.55 | 2023 | Alkindi |
| Revance Therapeutics, INC. | $42.54 | 2025 | Daxxify |
| Bayer Healthcare Pharmaceuticals INC. | $39.63 | 2021-2022 | |
| Ibsa Pharma INC. | $37.40 | 2020-2021 | |
| Galderma Laboratories, L.P. | $29.00 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.37 | 2019 | |
| Corcept Therapeutics | $24.78 | 2020 | |
| Pfizer INC. | $22.12 | 2025 | |
| Optos, INC. | $22.02 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Regeneron Pharmaceuticals, INC. | $17.44 | 2023 | Praluent, Evkeeza |
| Medtronic Minimed, INC. | $17.40 | 2019 | |
| Zealand Pharma US, INC. | $17.34 | 2021 | |
| Averitas Pharma INC. | $16.75 | 2023 | Qutenza |
| Intuity Medical INC | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priti Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.